Who owns the CARIS MOLECULAR TUMOR BOARD REPORT trademark?

The CARIS MOLECULAR TUMOR BOARD REPORT trademark is owned by Caris MPI, Inc..

What class is the CARIS MOLECULAR TUMOR BOARD REPORT trademark registered in?

The CARIS MOLECULAR TUMOR BOARD REPORT trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for CARIS MOLECULAR TUMOR BOARD REPORT?

The USPTO serial number for CARIS MOLECULAR TUMOR BOARD REPORT is 99701203.

What is the registration number for CARIS MOLECULAR TUMOR BOARD REPORT?

CARIS MOLECULAR TUMOR BOARD REPORT is registered under USPTO registration number 0.

CAR

USPTO Trademark Record

PENDING

CARIS MOLECULAR TUMOR BOARD REPORT

SN 99701203·Reg 0·Filed Mar 13, 2026

Owner Caris MPI, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

CARIS MOLECULAR TUMOR BOARD REPORT (Serial No. 99701203), Registration No. 0, is a pending US trademark filed on Mar 13, 2026 by Caris MPI, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Office Action response: December 24, 202677 days remaining

Mark Intelligence

CARIS MOLECULAR TUMOR BOARD REPORT (Reg. #0) is a pending US trademark that was filed in 2026 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Mar 13, 2026

SERIAL

99701203

REG#

Owner

Applicant

Caris MPI, Inc.

Entity

Corporation

State

Address

750 West John Carpenter Freeway, Ste. 800, Irving, TX, 75039

Country

Attorney

NameAnne C. Fleeson

Law firm

Anne C. Fleeson Womble Bond Dickinson (US) LLP

Docket

114025.0102

Address

One West Fourth Street, Winston-Salem, NC 27101, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateMar 13, 2026

Serial Number99701203

Registration No.0

Status DateSep 24, 2026

Mark TypeDesign with words

Attorney Docket114025.0102

Status DescriptionLive and pending, final refusal mailed

Filing Signals

FILED

2026

YEARS AGO

CLASSES

MADRID FILINGS

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 09, 2026

First use in commerce: Mar 09, 2026

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Mar 09, 2026

First use in commerce: Mar 09, 2026

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

14 events

FINAL REFUSAL WRITTEN

Sep 24, 2026

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Sep 24, 2026

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Sep 24, 2026

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 01, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 01, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 01, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jul 15, 2026

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 15, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 15, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 15, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 14, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 14, 2026

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Mar 13, 2026

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 13, 2026

APPLICATION FILING RECEIPT MAILED

CARIS MOLECULAR TUMOR BOARD REPORT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Caris MPI, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Anne C. Fleeson

Resources

Company